Insider · CIK 0001335581
Carolyn Beaver
director
Files at MNOV (MEDICINOVA INC), MXL (MAXLINEAR, INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2025 | MXL MAXLINEAR, INC | AGrant or award Restricted Stock Unitsderivative | +15,741 | $0.00 | $0 | 15,741 | Oct 10, 2025 |
| Jun 17, 2025 | MNOV MEDICINOVA INC | AGrant or award Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 20, 2025 |
| May 20, 2025 | MXL MAXLINEAR, INC | AGrant or award Restricted Stock Unitsderivative | +18,227 | $0.00 | $0 | 18,227 | May 22, 2025 |
| May 1, 2025 | MXL MAXLINEAR, INC | MOption exercise Common Stock | +12,141 | $0.00 | $0 | 23,575 | May 5, 2025 |
| May 1, 2025 | MXL MAXLINEAR, INC | MOption exercise Restricted Stock Unitsderivative | -12,141 | $0.00 | $0 | 0 | May 5, 2025 |
| Feb 12, 2025 | MNOV MEDICINOVA INC | AGrant or award Stock Option (Right to Buy)derivative | +24,500 | $0.00 | $0 | 24,500 | Feb 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.